Posted On: 06/18/2016 12:29:26 PM
Post# of 72443
Re: NotRichYet2 #24323
Would it surprise anyone to see that Seeking Alpha ran a big "buy buy buy" puff piece on AXON at IPO time?
Here's what "APBK Capital" said in the article:
http://seekingalpha.com/article/3246746-axova...-potential
They didn't mention that the purchase price was only 5 million dollars, because GSK decided it wasn't worth continuing to develop.
Here's what "APBK Capital" said in the article:
Quote:
Axovant Sciences purchased intellectual property rights to a leading Alzheimer's treatment currently in clinical trials.
http://seekingalpha.com/article/3246746-axova...-potential
They didn't mention that the purchase price was only 5 million dollars, because GSK decided it wasn't worth continuing to develop.
(0)
(0)Scroll down for more posts ▼
